PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications

The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies curr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Ulisse, Salvatore, Tuccilli, Chiara, Sorrenti, Salvatore, Antonelli, Alessandro, Fallahi, Poupak, D’Armiento, Eleonora, Catania, Antonio, Tartaglia, Francesco, Amabile, Maria Ida, Giacomelli, Laura, Metere, Alessio, Cornacchini, Nicola, Pironi, Daniele, Carbotta, Giovanni, Vergine, Massimo, Monti, Massimo, Baldini, Enke
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6471477/
https://ncbi.nlm.nih.gov/pubmed/30897754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20061405
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares